Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jérémie Théreaux"'
Autor:
Jérémie Thereaux, MD, PhD, Mohammed Bennani, PhD, Jean Khemis, MD, Elisabeth Ohayon, MD, Isabelle Visnovec Buissez, MD, Alexandre Lafourcade, MSc, Laëtitia Quiriconi, MSc, Caroline Philippe, MSc, Jean-Michel Oppert, MD, PhD
Publikováno v:
Annals of Surgery Open, Vol 5, Iss 2, p e420 (2024)
Objective:. This study compared the effectiveness of 4 main revisional bariatric surgery (RBS) sequences after sleeve gastrectomy (SG) and adjustable gastric banding (AGB), on the reimbursement of antidiabetic treatments in France. Background:. Few l
Externí odkaz:
https://doaj.org/article/0334199434f44bff8d7a268e1ad18ac7
Autor:
Caroline Gronnier, Cécile Chambrier, Alain Duhamel, Benoît Dervaux, Denis Collet, Delphine Vaudoyer, Jean-Marc Régimbeau, Jacques Jougon, Jérémie Théréaux, Gil Lebreton, Julie Veziant, Alain Valverde, Pablo Ortega-Deballon, François Pattou, Muriel Mathonnet, Julie Perinel, Laura Beyer-Berjot, David Fuks, Philippe Rouanet, Jérémie H. Lefevre, Pierre Cattan, Sophie Deguelte, Bernard Meunier, Jean-Jacques Tuech, Patrick Pessaux, Nicolas Carrere, Ephrem Salame, Eleonor Benaim, Bertrand Dousset, Simon Msika, Christophe Mariette, Guillaume Piessen, on behalf of FRENCH association
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-10 (2020)
Abstract Background Postoperative upper gastrointestinal fistula (PUGIF) is a devastating complication, leading to high mortality (reaching up to 80%), increased length of hospital stay, reduced health-related quality of life and increased health cos
Externí odkaz:
https://doaj.org/article/d4b7e166d2974ab5a932a60f73d03444
Autor:
Cyril Leven, Pauline Ménard, Isabelle Gouin-Thibault, Alice Ballerie, Karine Lacut, Edouard Ollier, Jérémie Théreaux
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 665 (2023)
Apixaban and rivaroxaban have first-line use for many patients needing anticoagulation for venous thromboembolism (VTE). The pharmacokinetics of these drugs in non-obese subjects have been extensively studied, and, while changes in pharmacokinetics h
Externí odkaz:
https://doaj.org/article/01f83f47119549369478f547bcfa1775
Autor:
Jérémie, Théreaux
Publikováno v:
La Revue du praticien. 72(2)
VENOUS THROMBOEMBOLIC RISK AFTER BARIATRIC surgeryvenous thromboembolism is widely considered as the first medical postoperative complication after bariatric surgery with a rate around 0.5% during the first 90 postoperative days. Pulmonary embolism i
Autor:
Sheraz R. Markar, Caroline Gronnier, Arnaud Pasquer, Alain Duhamel, Hélène Behal, Jérémie Théreaux, Johan Gagnière, Gil Lebreton, Cécile Brigand, Bernard Meunier, Denis Collet, Christophe Mariette, Guillaume Luc, Magalie Cabau, Jacques Jougon, Bogdan Badic, Patrick Lozach, Serge Cappeliez, Arnaud Alves, Renaud Flamein, Denis Pezet, Federica Pipitone, Bogdan Stan Iuga, Nicolas Contival, Eric Pappalardo, Styliani Mantziari, Flora Hec, Marguerite Vanderbeken, Williams Tessier, Nicolas Briez, Fabien Fredon, Alain Gainant, Muriel Mathonnet, Jean-Marc Bigourdan, Salim Mezoughi, Christian Ducerf, Jacques Baulieux, Oussama Baraket, Gilles Poncet, Delphine Vaudoyer, Peggy Jourdan Enfer, Laurent Villeneuve, Olivier Glehen, Thibault Coste, Jean Michel Fabre, Frédéric Marchal, Romain Frisoni, Ahmet Ayav, Laurent Brunaud, Laurent Bresler, Charlotte Cohen, Olivier Aze, Nicolas Venissac, Daniel Pop, Jérôme Mouroux, Ion Donici, Michel Prudhomme, Emanuele Felli, Stéphanie Lisunfui, Marie Seman, Gaelle Godiris Petit, Mehdi Karoui, Christophe Tresallet, Fabrice Ménégaux, Laurent Hannoun, Brice Malgras, Denis Lantuas, Karine Pautrat, Marc Pocard, Patrice Valleur
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2017, 75, pp.179-189. ⟨10.1016/j.ejca.2016.12.036⟩
European Journal of Cancer, Elsevier, 2017, 75, pp.179-189. ⟨10.1016/j.ejca.2016.12.036⟩
European Journal of Cancer, Elsevier, 2017, 75, pp.179-189
European Journal of Cancer, 2017, 75, pp.179-189. ⟨10.1016/j.ejca.2016.12.036⟩
European Journal of Cancer, Elsevier, 2017, 75, pp.179-189. ⟨10.1016/j.ejca.2016.12.036⟩
European Journal of Cancer, Elsevier, 2017, 75, pp.179-189
The objectives of this study were to compare peri-operative and long-term outcomes from oesophageal cancer (EC) (i) that arose in a previously radiated field (ECRF) versus primary (PEC) and among ECRF patients and (ii) radiotherapy-induced (RIEC) ver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0337c6982bce1e7bedbacf870c3bc759
https://hal.univ-brest.fr/hal-02050649
https://hal.univ-brest.fr/hal-02050649
Autor:
Sheraz R. Markar, Caroline Gronnier, Arnaud Pasquer, Alain Duhamel, Hélène Beal, Jérémie Théreaux, Johan Gagnière, Gil Lebreton, Cécile Brigand, Bernard Meunier, Denis Collet, Christophe Mariette, Abdennahceur Dhahri, Delphine Lignier, Cyril Cossé, Jean-Marc Regimbeau, Magalie Cabau, Jacques Jougon, Bogdan Badic, Patrick Lozach, Jean Pierre Bail, Serge Cappeliez, Issam El Nakadi, Arnaud Alves, Renaud Flamein, Denis Pezet, Federica Pipitone, Bogdan Stan-Iuga, Nicolas Contival, Eric Pappalardo, Simon Msika, Styliani Mantziari, Nicolas Demartines, Flora Hec, Marguerite Vanderbeken, Williams Tessier, Nicolas Briez, Fabien Fredon, Alain Gainant, Muriel Mathonnet, Jean Marc Bigourdan, Salim Mezoughi, Christian Ducerf, Jacques Baulieux, Jean-Yves Mabrut, Oussama Baraket, Gilles Poncet, Mustapha Adham, Delphine Vaudoyer, Peggy Jourdan Enfer, Laurent Villeneuve, Olivier Glehen, Thibault Coste, Jean-Michel Fabre, Frédéric Marchal, Romain Frisoni, Ahmet Ayav, Laurent Brunaud, Laurent Bresler, Charlotte Cohen, Olivier Aze, Nicolas Venissac, Daniel Pop, Jérôme Mouroux, Ion Donici, Michel Prudhomme, Emanuele Felli, Stéphanie Lisunfui, Marie Seman, Gaelle Godiris Petit, Mehdi Karoui, Christophe Tresallet, Fabrice Ménégaux, Jean-Christophe Vaillant, Laurent Hannoun, Brice Malgras, Denis Lantuas, Karine Pautrat, Marc Pocard, Patrice Valleur, Najim Chafai, Pierre Balladur, Magalie Lefrançois, Yann Parc, François Paye, Emmanuel Tiret, Marius Nedelcu, Letizia Laface, Thierry Perniceni, Brice Gayet, Alexandre Filipello, Jack Porcheron, Olivier Tiffet, Noémie Kamlet, Rodrigue Chemaly, Amandine Klipfel, Patrick Pessaux, Cecile Brigand, Serge Rohr, Nicolas Carrère, Chiara Da Re, Frédéric Dumont, Diane Goéré, Dominique Elias, Claude Bertrand
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2016, 56, pp.59-68. ⟨10.1016/j.ejca.2015.11.024⟩
European Journal of Cancer, Elsevier, 2016, 56, pp.59-68. ⟨10.1016/j.ejca.2015.11.024⟩
European Journal of Cancer, vol. 56, pp. 59-68
European Journal of Cancer, Elsevier, 2016, 56, pp.59-68. 〈10.1016/j.ejca.2015.11.024〉
European Journal of Cancer, 2016, 56, pp.59-68. ⟨10.1016/j.ejca.2015.11.024⟩
European Journal of Cancer, Elsevier, 2016, 56, pp.59-68. ⟨10.1016/j.ejca.2015.11.024⟩
European Journal of Cancer, vol. 56, pp. 59-68
European Journal of Cancer, Elsevier, 2016, 56, pp.59-68. 〈10.1016/j.ejca.2015.11.024〉
International audience; Aims: The aims of this study were to compare short-and long-term outcomes for clinical T2N0 oesophageal cancer with analysis of (i) primary surgery (S) versus neoadjuvant therapy plus surgery (NS), (ii) squamous cell carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::827b5dabbae7a17625957b8261aeb7fd
https://hal.univ-lorraine.fr/hal-01666517
https://hal.univ-lorraine.fr/hal-01666517
Autor:
Markar S; Sheraz Markar, Imperial College, London, United Kingdom; Caroline Gronnier, Christophe Mariette, and Alain Duhamel, Site de Recherche Intégrée sur le Cancer OncoLille; North of France University; University Hospital of Lille; Caroline Gronnier and Christophe Mariette, INSERM UMR S-1172, Jean Pierre Aubert Research Center, Lille; Arnaud Pasquer and Christophe Mariette, Edouard Herriot University Hospital, Lyon; Jérémie Théreaux, Cavale Blanche University Hospital, Brest; Mael Chalret du Rieu, Purpan University Hospital, Toulouse; Jérémie H. Lefevre, Saint Antoine University Hospital, Paris; Kathleen Turner, Pontchaillou University Hospital, Rennes; and Guillaume Luc, Haut-Levêque University Hospital, Bordeaux, France., Gronnier C; Sheraz Markar, Imperial College, London, United Kingdom; Caroline Gronnier, Christophe Mariette, and Alain Duhamel, Site de Recherche Intégrée sur le Cancer OncoLille; North of France University; University Hospital of Lille; Caroline Gronnier and Christophe Mariette, INSERM UMR S-1172, Jean Pierre Aubert Research Center, Lille; Arnaud Pasquer and Christophe Mariette, Edouard Herriot University Hospital, Lyon; Jérémie Théreaux, Cavale Blanche University Hospital, Brest; Mael Chalret du Rieu, Purpan University Hospital, Toulouse; Jérémie H. Lefevre, Saint Antoine University Hospital, Paris; Kathleen Turner, Pontchaillou University Hospital, Rennes; and Guillaume Luc, Haut-Levêque University Hospital, Bordeaux, France., Duhamel A; Sheraz Markar, Imperial College, London, United Kingdom; Caroline Gronnier, Christophe Mariette, and Alain Duhamel, Site de Recherche Intégrée sur le Cancer OncoLille; North of France University; University Hospital of Lille; Caroline Gronnier and Christophe Mariette, INSERM UMR S-1172, Jean Pierre Aubert Research Center, Lille; Arnaud Pasquer and Christophe Mariette, Edouard Herriot University Hospital, Lyon; Jérémie Théreaux, Cavale Blanche University Hospital, Brest; Mael Chalret du Rieu, Purpan University Hospital, Toulouse; Jérémie H. Lefevre, Saint Antoine University Hospital, Paris; Kathleen Turner, Pontchaillou University Hospital, Rennes; and Guillaume Luc, Haut-Levêque University Hospital, Bordeaux, France., Pasquer A; Sheraz Markar, Imperial College, London, United Kingdom; Caroline Gronnier, Christophe Mariette, and Alain Duhamel, Site de Recherche Intégrée sur le Cancer OncoLille; North of France University; University Hospital of Lille; Caroline Gronnier and Christophe Mariette, INSERM UMR S-1172, Jean Pierre Aubert Research Center, Lille; Arnaud Pasquer and Christophe Mariette, Edouard Herriot University Hospital, Lyon; Jérémie Théreaux, Cavale Blanche University Hospital, Brest; Mael Chalret du Rieu, Purpan University Hospital, Toulouse; Jérémie H. Lefevre, Saint Antoine University Hospital, Paris; Kathleen Turner, Pontchaillou University Hospital, Rennes; and Guillaume Luc, Haut-Levêque University Hospital, Bordeaux, France., Théreaux J; Sheraz Markar, Imperial College, London, United Kingdom; Caroline Gronnier, Christophe Mariette, and Alain Duhamel, Site de Recherche Intégrée sur le Cancer OncoLille; North of France University; University Hospital of Lille; Caroline Gronnier and Christophe Mariette, INSERM UMR S-1172, Jean Pierre Aubert Research Center, Lille; Arnaud Pasquer and Christophe Mariette, Edouard Herriot University Hospital, Lyon; Jérémie Théreaux, Cavale Blanche University Hospital, Brest; Mael Chalret du Rieu, Purpan University Hospital, Toulouse; Jérémie H. Lefevre, Saint Antoine University Hospital, Paris; Kathleen Turner, Pontchaillou University Hospital, Rennes; and Guillaume Luc, Haut-Levêque University Hospital, Bordeaux, France., du Rieu MC; Sheraz Markar, Imperial College, London, United Kingdom; Caroline Gronnier, Christophe Mariette, and Alain Duhamel, Site de Recherche Intégrée sur le Cancer OncoLille; North of France University; University Hospital of Lille; Caroline Gronnier and Christophe Mariette, INSERM UMR S-1172, Jean Pierre Aubert Research Center, Lille; Arnaud Pasquer and Christophe Mariette, Edouard Herriot University Hospital, Lyon; Jérémie Théreaux, Cavale Blanche University Hospital, Brest; Mael Chalret du Rieu, Purpan University Hospital, Toulouse; Jérémie H. Lefevre, Saint Antoine University Hospital, Paris; Kathleen Turner, Pontchaillou University Hospital, Rennes; and Guillaume Luc, Haut-Levêque University Hospital, Bordeaux, France., Lefevre JH; Sheraz Markar, Imperial College, London, United Kingdom; Caroline Gronnier, Christophe Mariette, and Alain Duhamel, Site de Recherche Intégrée sur le Cancer OncoLille; North of France University; University Hospital of Lille; Caroline Gronnier and Christophe Mariette, INSERM UMR S-1172, Jean Pierre Aubert Research Center, Lille; Arnaud Pasquer and Christophe Mariette, Edouard Herriot University Hospital, Lyon; Jérémie Théreaux, Cavale Blanche University Hospital, Brest; Mael Chalret du Rieu, Purpan University Hospital, Toulouse; Jérémie H. Lefevre, Saint Antoine University Hospital, Paris; Kathleen Turner, Pontchaillou University Hospital, Rennes; and Guillaume Luc, Haut-Levêque University Hospital, Bordeaux, France., Turner K; Sheraz Markar, Imperial College, London, United Kingdom; Caroline Gronnier, Christophe Mariette, and Alain Duhamel, Site de Recherche Intégrée sur le Cancer OncoLille; North of France University; University Hospital of Lille; Caroline Gronnier and Christophe Mariette, INSERM UMR S-1172, Jean Pierre Aubert Research Center, Lille; Arnaud Pasquer and Christophe Mariette, Edouard Herriot University Hospital, Lyon; Jérémie Théreaux, Cavale Blanche University Hospital, Brest; Mael Chalret du Rieu, Purpan University Hospital, Toulouse; Jérémie H. Lefevre, Saint Antoine University Hospital, Paris; Kathleen Turner, Pontchaillou University Hospital, Rennes; and Guillaume Luc, Haut-Levêque University Hospital, Bordeaux, France., Luc G; Sheraz Markar, Imperial College, London, United Kingdom; Caroline Gronnier, Christophe Mariette, and Alain Duhamel, Site de Recherche Intégrée sur le Cancer OncoLille; North of France University; University Hospital of Lille; Caroline Gronnier and Christophe Mariette, INSERM UMR S-1172, Jean Pierre Aubert Research Center, Lille; Arnaud Pasquer and Christophe Mariette, Edouard Herriot University Hospital, Lyon; Jérémie Théreaux, Cavale Blanche University Hospital, Brest; Mael Chalret du Rieu, Purpan University Hospital, Toulouse; Jérémie H. Lefevre, Saint Antoine University Hospital, Paris; Kathleen Turner, Pontchaillou University Hospital, Rennes; and Guillaume Luc, Haut-Levêque University Hospital, Bordeaux, France., Mariette C; Sheraz Markar, Imperial College, London, United Kingdom; Caroline Gronnier, Christophe Mariette, and Alain Duhamel, Site de Recherche Intégrée sur le Cancer OncoLille; North of France University; University Hospital of Lille; Caroline Gronnier and Christophe Mariette, INSERM UMR S-1172, Jean Pierre Aubert Research Center, Lille; Arnaud Pasquer and Christophe Mariette, Edouard Herriot University Hospital, Lyon; Jérémie Théreaux, Cavale Blanche University Hospital, Brest; Mael Chalret du Rieu, Purpan University Hospital, Toulouse; Jérémie H. Lefevre, Saint Antoine University Hospital, Paris; Kathleen Turner, Pontchaillou University Hospital, Rennes; and Guillaume Luc, Haut-Levêque University Hospital, Bordeaux, France. christophe.mariette@chru-lille.fr.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2015 Nov 20; Vol. 33 (33), pp. 3866-73. Date of Electronic Publication: 2015 Jul 20.